LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

LLY

732.88

+0.07%↑

JNJ

177.5

+0.27%↑

ABBV

211.68

+0.66%↑

UNH

308.79

-0.21%↓

AZN

80.16

+0.34%↑

Search

ReShape Lifesciences Inc

Gesloten

3.35 13.95

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.35

Max

3.35

Dividenden

By Dow Jones

Volgende Winsten

12 nov 2025

ReShape Lifesciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

21 aug 2025, 23:45 UTC

Winsten

Li Ning's 1st Half Profit Drops on Higher Tax Expense

21 aug 2025, 21:29 UTC

Winsten

Intuit 4Q Sales Jump 20%, Expects Slower Growth Ahead -- Update

21 aug 2025, 21:12 UTC

Winsten

Workday 2Q Profit Rises With Jump in Revenue

21 aug 2025, 23:47 UTC

Marktinformatie

Nikkei May Trade in Range Amid Caution Over U.S. Econ Outlook -- Market Talk

21 aug 2025, 23:30 UTC

Winsten

Li Ning's 1H Profit Drops on Higher Tax Expense

21 aug 2025, 23:22 UTC

Winsten

Resolute Mining Reiterates 2025 Output, Cost, Capex Guidance

21 aug 2025, 23:22 UTC

Winsten

Resolute Mining Cash, Bullion Worth A$158.7 Million at June 30

21 aug 2025, 23:21 UTC

Marktinformatie

Global Equities Roundup: Market Talk

21 aug 2025, 23:21 UTC

Marktinformatie

Intuit Sees Early Traction with AI Agents -- Market Talk

21 aug 2025, 23:21 UTC

Winsten

Resolute Mining Net Cash A$109.9 Million at June 30

21 aug 2025, 23:20 UTC

Winsten

Resolute Mining 1H Revenue A$447.5 Million, Up 31% On-Year

21 aug 2025, 23:20 UTC

Winsten

Resolute Mining 1H Ebitda A$211.1 Million, Up 81% On-Year

21 aug 2025, 23:20 UTC

Winsten

Resolute Mining Won't Pay an Interim Dividend

21 aug 2025, 23:19 UTC

Winsten

Resolute Mining 1H Net Profit A$58.8 Million Vs A$20.9 Million Year Earlier

21 aug 2025, 22:37 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

21 aug 2025, 22:36 UTC

Marktinformatie

Peter Warren Automotive Moving Into Higher Gear -- Market Talk

21 aug 2025, 22:35 UTC

Acquisities, Fusies, Overnames

TSMC Executives Considered Giving Back Chips Act Funds if Government Asked for Equity, Sources Say -- WSJ

21 aug 2025, 22:35 UTC

Acquisities, Fusies, Overnames

How Trump Will Decide Which Chips Act Companies Must Give Up Equity -- WSJ

21 aug 2025, 22:35 UTC

Acquisities, Fusies, Overnames

Commerce Secretary Lutnick Previously Indicated Government May Hold Equity in Semiconductor Companies Other Than Intel -- WSJ

21 aug 2025, 22:35 UTC

Acquisities, Fusies, Overnames

Administration Might Take Equity in Smaller Companies Receiving Funds Under the Act, Official Says -- WSJ

21 aug 2025, 22:35 UTC

Acquisities, Fusies, Overnames

Trump Administration Considers Taking Stakes in Companies Receiving Chips Act Money, Source Says -- WSJ

21 aug 2025, 22:33 UTC

Marktinformatie

Australia Shares Set to Retreat From Record -- Market Talk

21 aug 2025, 22:20 UTC

Winsten

Regis Resources Cash, Bullion A$517.2 Million at June 30

21 aug 2025, 22:19 UTC

Winsten

Regis Resources FY Ebitda A$780.1 Million Vs A$296.9 Million Year Prior

21 aug 2025, 22:18 UTC

Winsten

Regis Resources FY Revenue A$1.65 Billion, Up 30% On-Year

21 aug 2025, 22:18 UTC

Winsten

Regis Resources to Pay Final Dividend of 5 Australian Cents/Share

21 aug 2025, 22:17 UTC

Winsten

Regis Resources Net Profit A$254.4 Million Vs A$186.0 Million Loss Year Prior

21 aug 2025, 22:14 UTC

Marktinformatie
Winsten

Global Equities Roundup: Market Talk

21 aug 2025, 22:14 UTC

Marktinformatie
Winsten

Brambles' Stock Surge Suggests Comfort With Guidance -- Market Talk

21 aug 2025, 21:43 UTC

Populaire aandelen

Intuit, Ross Stores, Workday: Stocks to Watch Afterhours -- WSJ

Peer Vergelijking

Prijswijziging

ReShape Lifesciences Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Financieel

$